Earnings Presentation 4 th Quarter 2019 1 Disclaimer This - PowerPoint PPT Presentation

Earnings Presentation 4 th Quarter 2019 1

Disclaimer This presentation contains, or may be deemed to contain, “forward -looking statements” . By their nature, forward looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The future results of Alpek, S.A.B. de C.V. and its subsidiaries may differ from the results expressed in, or implied by the forward-looking statements set out herein, possibly to a material degree.

2019 Highlights 2nd Highest Reported EBITDA in Alpek’s history (U.S. $850 million) Comparable EBITDA exceeded 2019 Guidance figures • U.S. $722 million vs. U.S. $718 million Finalized sale of Cogeneration plants for U.S. $801 million in 2019 as expected Strong financial improvement as Leverage reduced to 1.6x Net Debt to EBITDA Improved PTA/PET capacity balance & 1 st expansion outside of Americas through acquisition of 350K PET facility in Wilton, UK 3

Relevant References: Crude Oil Crude Oil prices remained stable during 4Q19 US$/Bbl Brent Crude Oil Price 4Q 120 Avg. 100 99 80 71 Guidance 64 68 60 54 53 44 40 20 2014 2015 2016 2017 2018 2019 Source: Bloomberg 4

Relevant References: Paraxylene Px prices were stable during 4Q19 US$/Ton NA Px Contract Price 2,000 1,708 1,635 1,641 US$22/ton 1,500 1,382 increase from 1,258 1,282 Sep.’19 to Dec.’19 1,165 977 1,056 1,100 1,077 992 989 955 937 924 924 1,000 900 898 878 829 500 0 2011 2012 2013 2014 2015 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 2016 2017 2018 2019 Source: IHS 5

Relevant References: Integrated PET Margins ’19 Avg. of U.S. $306/ton exceeded guidance, but declined in 4Q Asian Margins (Px / MEG to PET) US$/Ton 600 China 500 478 393 400 377 370 342 333 324 304 284 346 300 277 193 276 263 260 255 248 240 214 242 227 227 211 212 210 215 238 164 214 200 202 204 208 184 189 186 174 PET 145 180 165 148 147 153 100 200 155 140 133 135 117 110 104 80 81 82 PTA 74 69 69 71 72 62 64 63 60 58 0 2011 2012 2013 2014 2015 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 2016 2017 2018 2019 Source: ICIS, PCI, CCFGroup 6

Relevant References: Propylene & Polypropylene Slight decrease in both PGP contract prices & PP margins in 4Q19 NA Propylene Contract Price (PGP) NA Polypropylene Margin (PP to PGP) cpp cpp 80 28 27 76 26 71 69 24 70 24 23 23 22 22 22 60 60 22 21 20 60 20 20 19 53 52 51 18 50 45 15 16 39 13 38 38 40 37 14 35 12 34 12 12 30 10 8 20 6 4 10 2 0 0 11 12 13 14 15 16 17 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 11 12 13 14 15 16 17 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 2018 2019 2018 2019 Source: IHS 7

EBITDA 2 nd highest Reported EBITDA in Alpek’s history Alpek EBITDA (US$M) 1,063 220 +83% 850 369 Badwill 356 804 188 PQS CoGen 722 Sale 188 220 234 218 213 189 181 843 170 172 148 662 274 239 194 Reported 181 167 161 149 EBITDA 140 2018 2019 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 2018 2019 Comparable EBITDA exc. RMCF 1 Comparable EBITDA (1) Raw Material Carry Forward 8

EBITDA Breakdown Better than expected margins in both segments offset by Px price drop 188 Others 11 173 172 6 167 2 2 6 1 P&C 52 EBITDA 46 46 42 4Q19 vs. 4Q19G 135 125 123 122 Polyester (US$M) 4Q19G Polyester P&C Others 4Q19 RMCF 1 4Q19 Inventories Others 4Q19 Comparable Comparable Reported (w. RMCF) 1 789 11 41 722 718 67 29 Others 662 68 231 9 190 P&C EBITDA 231 218 2019 vs. 2019G 512 541 474 Polyester (US$M) 428 RMCF 1 2019G Polyester P&C Others 2019 2019 Inventories Others 2019 Comparable Comparable Reported (w. RMCF) 1 (1) Raw Material Carry Forward 9

Raw Material Carry Forward Effect (RMCF) Comparable EBITDA + RMCF 1 almost matched 2018 record figures 2019 2018 Delta 4T 2 4T 3 US$M 1T 2T 3T Total 1T 2T 3T Total 1T 2T 3T 4T Total 140 161 194 167 662 181 239 274 149 843 (41) (78) (80) 18 (181) Reported EBITDA Inventory Adjustment (19) (27) (16) (6) (68) 16 20 33 (28) 41 (35) (48) (49) 22 (109) 11 (1) (3) 1 9 (5) 1 7 (4) (2) 16 (1) (10) 5 10 Others 148 189 213 172 722 170 218 234 181 804 (23) (29) (21) (10) (82) Comparable EBITDA Raw Material Carry (19) (28) (18) (2) (67) 11 9 (18) 2 4 (30) (36) (1) (4) (70) Forward Comparable EBITDA + 167 217 231 173 789 160 210 251 179 800 7 7 (20) (6) (11) Raw Material Carry Forward (1) Raw Material Carry Forward: Effect on margin generated from price change to raw materials between purchase vs. actual consumption. Positive or negative depending on price change (2) Excludes PQS Badwill Excludes Cogeneration plants’ sale (3) 10

Leverage Net debt reduced by U.S. $706 million resulting in 1.6x leverage levels Net Debt (US$M) LTM EBITDA (US$M) Net Debt/EBITDA (Times) 2,200 1,063 3.1 1,022 2,084 2,036 2.9 944 1,832 864 850 834 2.4 1,637 1,603 2.2 2.2 1.9 1,330 1,270 1.7 564 1.6 407 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 11

2019 Guidance Alpek met its Comparable EBITDA Guidance for 2019 Alpek Comparable EBITDA Guidance (US$M) Alpek EBITDA Guidance + CoGen (US$M) US$68M US$789M inventory losses including RMCF 1 +4 -8 60 722 718 918 910 662 CoGen 172 188 200 Sale 4Q19 167 Comparable 550 722 718 EBITDA YTD Sep19 495 2019 Reported Net 2019 2019 2019 2019 Guidance EBITDA Extraordinary Comparable Guidance (ex- Items EBITDA Cogen Sale) (1) Raw Material Carry Forward 12

For Additional Information IR@alpek.com / +52 (818) 748-1146 Alejandro • 8 Years at Alfa/Alpek Elizondo • Previously held roles as Director of Logistics & Procurement at Indelpro, Director of Energy Markets at IRO Alfa, and Project Leader at The Boston Consulting Group • BS in Industrial Engineering from Cornell University and MBA from Stanford Graduate School of Business aelizondo@alpek.com Alejandra • 7 Years at Alfa/Alpek Bustamante • Previously held roles in Human Resources, Talent & Culture at Alfa and Axtel IR Manager • BA in International Relations from ITESM abustamante@alpek.com 13

14